Sign in

CIK 0001533615 · Accelerated filer

Chiron Real Estate Inc.

Sign in to watch
Ticker
XRN
Exchange
NYSE
Industry
Real Estate Investment Trusts
FY end
Dec 31
Incorporated
MD
Entity type
operating
EIN
464757266
Phone
202-524-6851
Business address
7373 WISCONSIN AVENUE, SUITE 800, BETHESDA, MD, 20814
Former names
Global Medical REIT Inc., SCOOP MEDIA, INC.

Securities

  • XRN Common Stock NYSE
  • XRN-PA Series A Cumulative Redeemable Preferred Stock NYSE
  • XRN-PB 8.00% Series B Cumulative Redeemable Preferred Stock, $0.001 par value per share NYSE
Open-market buys, last 90 days
$18,190
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$18,190. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Whitlock Matthew Fitzsimmons +$18K Chief Investment Officer 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-27 Holley Danica Chief Administrative Officer Grant or award · Option (Right to buy) +20,992 20,992
2026-08-27 Barber Jamie Allen General Counsel and Secretary Grant or award · Option (Right to buy) +19,084 19,084
2026-08-27 Decker Mark Okey Jr CEO and President Grant or award · Option (Right to buy) +49,618 49,618
2026-08-27 KIERNAN ROBERT J CFO and Treasurer Grant or award · Option (Right to buy) +29,580 29,580
2026-08-27 Zeiller Robert Harold See Remarks Grant or award · Option (Right to buy) +23,855 23,855
2026-08-27 Roseth Aaron Robert COO Grant or award · Option (Right to buy) +23,855 23,855
2026-08-27 Whitlock Matthew Fitzsimmons Chief Investment Officer Grant or award · Option (Right to buy) +28,626 28,626
2026-08-17 Whitlock Matthew Fitzsimmons Chief Investment Officer Purchase +500 $36.38 $18K 2,000
2026-08-14 Whitlock Matthew Fitzsimmons Chief Investment Officer Purchase +500 $37.21 $19K 1,500
2026-08-12 Roseth Aaron Robert COO Purchase +13,500 $36.73 $496K 13,500
2026-08-11 Decker Mark Okey Jr CEO and President Purchase +6,875 $35.92 $247K 75,199
2026-08-11 Decker Mark Okey Jr CEO and President Purchase +550 $36.00 $20K 68,324
2026-08-11 Fitzgerald Charles Director Purchase +14,000 $35.78 $501K 138,893
2026-08-10 Decker Mark Okey Jr CEO and President Purchase +8,000 $35.88 $287K 67,774
2026-08-10 Fitzgerald Charles Director Purchase +27,600 $35.94 $992K 124,893
2026-08-03 Roseth Aaron Robert Chief Operating Officer Grant or award · LTIP Unit (Right to Buy) +7,418 7,418
2026-08-03 Zeiller Robert Harold See Remarks Grant or award · LTIP Unit (Right to Buy) +7,418 9,895
2026-08-03 Whitlock Matthew Fitzsimmons Chief Investment Officer Grant or award · LTIP Unit (Right to Buy) +9,442 9,442
2026-07-16 Zeiller Robert Harold See Remarks Grant or award · LTIP Unit (Right to Buy) +2,477 2,477
2026-05-29 Fitzgerald Charles Director Grant or award · 6.00% SERIES C CONVERTIBLE PREFERRED STOCK +220,000 $100.00 $22.0M 220,000

Page 1 of 7 · 132 trades